Abstract
Recently, with the purpose of enhancing the potency of epidermal growth factor receptor (EGFR)-based therapies, we designed a novel strategy termed 'Cascade-release targeting' that seeks to develop molecules capable of degrading to multiple tyrosine kinase (TK) inhibitors and highly reactive electrophiles, in a stepwise fashion. Here we report on the first prototype of this model, RB24, a masked methyltriazene, that in addition to being an inhibitor on its own was designed to degrade to RB14, ZR08, RB10+a DNA alkylating methyldiazonium species. The cascade degradation of RB24 requires the generation of two reactive electrophiles: (a) an iminium ion and (b) a methyldiazonium ion. Thus, we surmise that these species could alkylate the active site of EGFR, thereby irreversibly blocking its action and that DNA damage could be induced by the methyldiazonium. Using the EGFR-overexpressing human epidermoid carcinoma of the vulva cell line, A431, we demonstrate herein that (a) RB24 and its derived species (e.g. RB14, ZR08) irreversibly inhibit EGFR autophosphorylation, (b) RB24 induced significant levels of DNA strand breaks, (c) sustained inhibition of EGFR by RB24 was associated with blockade of MAPK activation and c-fos gene express...Continue Reading
References
Feb 15, 1987·Biochemical Pharmacology·M J Tisdale
Feb 1, 1986·Carcinogenesis·N W GibsonK Vaughan
Oct 1, 1985·Environmental Health Perspectives·W J BodellM L Rosenblum
Nov 1, 1995·Clinical & Experimental Metastasis·H XieA Wells
Jan 1, 1995·Progress in Nucleic Acid Research and Molecular Biology·A E PeggR C Moschel
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·R B Mitchell, M E Dolan
Jun 1, 1993·British Journal of Cancer·J C BaerG P Margison
Sep 1, 1996·Clinical & Experimental Metastasis·T TurnerA Wells
Feb 1, 1997·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H Meden, W Kuhn
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·D W FryE M Dobrusin
May 29, 1999·Journal of Medicinal Chemistry·J B SmaillS J Patmore
Mar 30, 2000·International Journal of Cancer. Journal International Du Cancer·A M Tari, G Lopez-Berestein
Feb 7, 2001·Mutation Research·J P McNameeP V Bellier
Feb 7, 2001·Journal of Medicinal Chemistry·J B SmaillW A Denny
Nov 4, 2000·Biochemical and Biophysical Research Communications·X ChenZ Wang
Mar 5, 2002·British Journal of Cancer·N MagnéG Milano
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm RansonEric K Rowinsky
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Fouad BrahimiBertrand J Jean-Claude
Dec 24, 2002·Cancer Chemotherapy and Pharmacology·Qiyu QiuBertrand J Jean-Claude
Dec 24, 2002·Cancer Chemotherapy and Pharmacology·Stephanie L MathesonBertrand J Jean-Claude
Mar 20, 2003·Radiation Research·Adly YacoubMichael P Hagan
Jul 11, 2003·Lancet·Janet E Dancey, Boris Freidlin
Sep 19, 2003·Journal of Medicinal Chemistry·Zakaria RachidBertrand J Jean-Claude
Dec 3, 2003·Journal of Medicinal Chemistry·Ranjita BanerjeeBertrand J Jean-Claude
Mar 3, 2004·The Prostate·Qiyu QiuBertrand J Jean-Claude
Mar 10, 2004·Biochemical Pharmacology·Stephanie L MathesonBertrand J Jean-Claude
Sep 11, 2004·The Journal of Pharmacology and Experimental Therapeutics·Stephanie L MathesonBertrand J Jean-Claude
Citations
Feb 1, 2012·The Prostate·Youqiang FangBertrand J Jean-Claude
May 15, 2010·Journal of Neuro-oncology·H L WattB J Jean-Claude
Mar 30, 2010·The Journal of Pharmacology and Experimental Therapeutics·Ranjita BanerjeeBertrand J Jean-Claude
Jun 28, 2019·Current Pharmaceutical Design·Ana P FranciscoMaria J Perry
Nov 13, 2018·Oncotarget·Martin RuppBertrand J Jean-Claude
Apr 30, 2010·Investigational New Drugs·Meaghan MacPheeBertrand J Jean-Claude
Feb 9, 2007·Journal of Cellular Physiology·Thomas W GruntChristoph C Zielinski
Aug 13, 2017·BMC Cancer·Zhor Senhaji MouhriBertrand Jean-Claude
Mar 7, 2017·Future Medicinal Chemistry·Guohui SunRugang Zhong
Jan 26, 2011·Molecular Cancer Research : MCR·Ying HuangBertrand J Jean-Claude
Feb 19, 2008·Molecular Cancer Therapeutics·Andrea CavazzoniPier Giorgio Petronini
Mar 7, 2021·Pharmaceuticals·Anne-Laure Larroque-LombardBen Allal